Growth Metrics

Pfizer (PFE) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $120.4 billion.

  • Pfizer's Goodwill & Intangibles fell 632.49% to $120.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $120.4 billion, marking a year-over-year decrease of 632.49%. This contributed to the annual value of $123.9 billion for FY2024, which is 659.09% down from last year.
  • According to the latest figures from Q3 2025, Pfizer's Goodwill & Intangibles is $120.4 billion, which was down 632.49% from $121.7 billion recorded in Q2 2025.
  • In the past 5 years, Pfizer's Goodwill & Intangibles registered a high of $132.7 billion during Q4 2023, and its lowest value of $74.4 billion during Q4 2021.
  • Over the past 5 years, Pfizer's median Goodwill & Intangibles value was $93.5 billion (recorded in 2023), while the average stood at $101.4 billion.
  • Per our database at Business Quant, Pfizer's Goodwill & Intangibles tumbled by 1655.2% in 2021 and then skyrocketed by 4134.45% in 2024.
  • Over the past 5 years, Pfizer's Goodwill & Intangibles (Quarter) stood at $74.4 billion in 2021, then increased by 27.42% to $94.7 billion in 2022, then soared by 40.04% to $132.7 billion in 2023, then decreased by 6.59% to $123.9 billion in 2024, then decreased by 2.83% to $120.4 billion in 2025.
  • Its Goodwill & Intangibles stands at $120.4 billion for Q3 2025, versus $121.7 billion for Q2 2025 and $122.4 billion for Q1 2025.